Objective: To summarize evidence on the rates and drivers of progression from
normoglycemia to prediabetes and/or diabetes mellitus (hereafter “diabetes”) in antiretroviral …

Background Risk factors for coronavirus disease 2019 (COVID-19) death in sub-Saharan
Africa and the effects of human immunodeficiency virus (HIV) and tuberculosis on COVID-19 …

Background: The use of integrase inhibitor-based antiretroviral therapy could be associated
with worse weight and metabolic outcomes in patients with HIV infection. Methods: PubMed …

Objective: The primary objective was to explore weight and BMI changes in people with HIV
(PWH) undergoing integrase strand transfer inhibitors (INSTI)-based regimens (vs. non …

Background Combined antiretroviral therapy (cART) dramatically improved survival in
people living with HIV (PLWH) but is associated with weight gain (WG), raising concern for a …

Abstract Purpose People with HIV (PHIV) with access to modern antiretroviral therapy (ART)
face a two-fold increased risk of heart failure as compared with non-HIV-infected individuals …

With advances in the treatment of HIV, people living with HIV (PLWH) are now expected to
have a near-normal life expectancy, but challenges remain in the form of substantially …

Objective Obesity is a common, modifiable cardiovascular and cerebrovascular risk factor.
Among people with HIV, obesity may contribute to multisystem dysregulation including …

In the era of highly active antiretroviral therapy (HAART), obesity is increasingly being
reported among people living with HIV (PLHIV). In this study, we reviewed published …

Background To describe prevalence, incidence and risk factors for sarcopenic obesity (SO)
phenotypes in people living with HIV (PWH) and their association with subclinical …